<?xml version="1.0" encoding="UTF-8"?>
<ref id="cit0104">
 <label>[104]</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Wu</surname>
    <given-names>H</given-names>
   </string-name>, 
   <string-name>
    <surname>Li</surname>
    <given-names>J</given-names>
   </string-name>, 
   <string-name>
    <surname>Guo</surname>
    <given-names>E</given-names>
   </string-name>, et al
  </person-group>
  <article-title>MiR-410 acts as a tumor suppressor in estrogen receptor-positive breast cancer cells by directly targeting ERLIN2 via the ERS pathway</article-title>. 
  <source>Cell Physiol Biochem</source>. 
  <year>2018</year>;
  <volume>48</volume>(
  <issue>2</issue>):
  <fpage>461</fpage>â€“
  <lpage>474</lpage>.
  <pub-id pub-id-type="pmid">30016800</pub-id>
 </mixed-citation>
</ref>
